LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Lexaria Bioscience Corp.

740 McCurdy Road
Unit 100
Kelowna, BC V1X 2P7
Canada
250-765-6424
http://www.lexariabioscience.com

Sector(s)Consumer Defensive
IndustryPackaged Foods
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Christopher A. BunkaChairman & CEO223.28kN/A1962
Mr. John M. DochertyPres & Director195.74kN/A1969
Mr. Allan Spissinger C.A., CPACFO, Corp. Sec. & Treasurer112.38kN/A1969
Vanessa CarleHead of LegalN/AN/AN/A
Dr. Philip AinslieAdvisor & ConsultantN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology that changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing, and higher effectiveness for lipophilic active molecules. DehydraTECH enhances bio-absorption, reduces time of onset, and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine, and other molecules. The company has licensed DehydraTECH to various companies in the cannabis industry for use in cannabinoid beverages, edibles, and oral products, as well as to tobacco producers for the development of smokeless oral-based nicotine products. It is also involved in the production of enhanced oral products under the ViPova, Lexaria Energy, TurboCBD, and ChrgD+ brands. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

Corporate Governance

Lexaria Bioscience Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.